What is Nectar?
Nectar Allergy & Asthma specializes in personalized allergy testing and treatment, offering both in-person and online services. The company focuses on improving the quality of life for individuals, including adults and children, suffering from allergies, asthma, and eczema through customized treatment plans and immunotherapy. Based in New York City, Nectar aims to make its services accessible by accepting most major insurances and providing flexible appointment scheduling, including online options.
How much funding has Nectar raised?
Nectar has raised a total of $16.5M across 1 funding round:
Series A
$16.5M
Series A (2022): $16.5M with participation from Obvious Ventures, Harmony Partners, and Juxtapose
Key Investors in Nectar
Obvious Ventures
Obvious Ventures is a creative and design firm that transforms client ideas into compelling marketing and communications materials across multiple formats and channels, specializing in strategic design, copywriting, and illustration.
Harmony Partners
Harmony Partners is a venture capital firm that provides flexible financing options with simple, entrepreneur-friendly deal terms to help founders scale their innovative products, leveraging over 30 years of experience and a broad network.
Juxtapose
Juxtapose is an inception-stage investment firm exclusively focused on building industry-transforming businesses from the ground up, partnering with experienced operators to found and scale category-defining technology companies.
What's next for Nectar?
The recent major strategic investment in Nectar signals a pivotal phase for the company, likely focused on scaling its operations and expanding its reach within the healthcare market. This capital infusion is expected to fuel advancements in their personalized treatment methodologies and potentially broaden their service offerings. With a focus on patient education and flexible care options, Nectar is positioned to further solidify its presence and enhance its impact on managing chronic respiratory and allergic conditions.
See full Nectar company page
